Uncategorized
Aerie Pharmaceuticals to Present at the RBC Capital Markets 2017 Global Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that Casey Kopczynski, Ph.D., Chief Scientific Officer, will present in a fireside chat discussion at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22, 2017 at 8:30 a.m. Eastern Time